Literature DB >> 3659664

The probability of inevitability: the inherent impossibility of validating criteria for brain death or 'irreversibility' through clinical studies.

D A Shewmon1.   

Abstract

A great need persists for diagnostic criteria for both brain death in young children and irreversible loss of consciousness at all ages. This article examines the inferences derived from a hypothetical confirmatory study in which all of the N patients who fulfilled the criterion did in fact experience brain death (irreversibility). A Bayesian methodology proves that, for N in the range of a large clinical study, estimations of prior probabilities are, for all practical purposes, irrelevant to the calculation of the posterior probabilities. The risk of a false positive diagnosis for the next patient who meets the criterion is approximately 1/(N + 2). The chance of at least one false positive diagnosis among the next (N + 1) patients who meet the criterion is around 50 per cent. Thus, achievement of the requisite moral certainty of a declaration of death (irreversibility) necessitates an impossibly large N for the study. This does not mean that one cannot diagnose death, but rather that the validity of the diagnostic criteria must be self-evident on a priori grounds, and that confirmatory studies are necessarily either inadequate or superfluous.

Entities:  

Mesh:

Year:  1987        PMID: 3659664     DOI: 10.1002/sim.4780060503

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  2 in total

1.  Declaring pediatric brain death: current practice in a Canadian pediatric critical care unit.

Authors:  B L Parker; T C Frewen; S D Levin; D A Ramsay; G B Young; R H Reid; N C Singh; J M Gillett
Journal:  CMAJ       Date:  1995-10-01       Impact factor: 8.262

2.  Pro/con ethics debate: should mechanical ventilation be continued to allow for progression to brain death so that organs can be donated?

Authors:  Michael Parker; Sam D Shemie
Journal:  Crit Care       Date:  2002-08-15       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.